SecBot SecBot
8-K ·Filed Mar 6, 2026

PRCT

PROCEPT BioRobotics Corp
NEUTRAL
Impact 3/10
Horizonmonths Processed8mo ago SEC0001588978-26-000013
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

No immediate trading implications; monitor for any future strategic shifts or commentary from the new director, but this is a standard board expansion with an experienced medical device executive.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$24.22
T+0 close · Mar 6, 2026 · via day close
Latest settled
+15.03%
T+60 · $27.86
Vs SPY
+2.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 6 $24.22entry
  2. T+1 · 8mo ago +4.29%α +3.45% · $25.26
  3. T+5 · 8mo ago +12.01%α +13.54% · $27.13
  4. T+20 · 8mo ago −1.82%α +0.23% · $23.78
  5. T+60 · 6mo ago +15.03%α +2.25% · $27.86
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Procept BioRobotics appointed Daniel Puckett to its board of directors and audit committee, effective March 5, 2026. Puckett, a former CFO of Shockwave Medical, brings medical device industry experience but the move is a routine governance update with no immediate financial impact.

Key Facts

  • Daniel Puckett appointed to board of directors and audit committee effective March 5, 2026
  • Board size increased from eight to nine members
  • Puckett classified as Class III director with term expiring at 2027 annual meeting
  • Puckett is independent and previously served as CFO of Shockwave Medical until February 2024
  • No departures or executive changes announced

Financial Impact

Minimal to none

board compositiongovernance

Risk Factors

  • None identified from this filing
  • Integration of new director may take time to influence strategy

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001588978-26-000013
Document: 0001588978-26-000013-index-headers.html0001588978-26-000013
Document: 0001588978-26-000013-index.html0001588978-26-000013
Document: 0001588978-26-000013.txt0001588978-26-000013

Track record

16 reports on PRCT

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +22.73% at T+60 after the Feb 26, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 6, 202610d ago 144 Neutral 2/10 Entry $20.62 Now $23.54 +14.16% settles Feb 4
  2. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $20.27 Now $23.54 +16.13% settles Feb 3
  3. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $19.20 Now $23.54 +22.60% settles Jan 28
  4. Oct 2, 20266w ago 8-K Neutral 2/10 Entry $17.82 Now $23.54 +32.10% settles Dec 30
  5. Sep 24, 20267w ago 8-K Neutral 3/10 Entry $17.20 Now $23.54 +36.86% settles Dec 21
  6. Aug 10, 202614w ago Insider Buy Bullish 5/10 Entry $21.71 to $19.98 Now $23.54 +8.43% ▼ −7.99% −6.09% vs SPY
  7. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
  8. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
  9. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
  10. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 6, 2026